AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7972619 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled ambulatory activities (alphabetizing, editing task, brisk walk, solving word puzzles, eating lunch)
Number of subjects: 37
Study 7972619 — intervention group
Group type: COMPARATOR
Intervention: Laboratory measurements
Number of subjects: 37
Study 2702243 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) alone
Number of subjects: 30
Study 2702243 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) + Salbutamol (S)
Number of subjects: 30
Study 2702243 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 4684623 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana cigarette containing 4.8 mg Delta(9)-THC
Number of subjects: 75
Study 4684623 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana cigarette containing 9.1 mg Delta(9)-THC
Number of subjects: 75
Study 4684623 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana cigarette containing less than 0.01 mg Delta(9)-THC
Number of subjects: 75
Study 4684623 — intervention group
Group type: EXPERIMENTAL
Intervention: Low doses of marijuana
Number of subjects: 75
Study 4684623 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of marijuana
Number of subjects: 75
Study 4684623 — intervention group
Group type: EXPERIMENTAL
Intervention: Marijuana (all doses)
Number of subjects: 75
Study 29893313 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral salpingectomy (Group 1; n = 15)
Number of subjects: 62
Study 29893313 — intervention group
Group type: COMPARATOR
Intervention: No bilateral salpingectomy (Group 2; n = 15)
Number of subjects: 62
Study 27454135 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression Garment (CG)
Number of subjects: 18
Study 27454135 — intervention group
Group type: COMPARATOR
Intervention: Normal Garment (CON)
Number of subjects: 18
Study 25240806 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD therapy for women
Number of subjects: 0
Study 22516403 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic lead shielding during radial access
Number of subjects: 210
Study 22516403 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic lead shielding during femoral access
Number of subjects: 210
Study 19935821 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary practice during the complementary feeding period, primarily using commercial food products.
Number of subjects: 286
Study 19935821 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk or formula consumption.
Number of subjects: 286
Study 19935821 — intervention group
Group type: COMPARATOR
Intervention: Commercial complementary food.
Number of subjects: 286
Study 18219053 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram
Number of subjects: 8
Study 18219053 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 15142210 — intervention group
Group type: EXPERIMENTAL
Intervention: Vector-ultrasonic system (VUS)
Number of subjects: 38
Study 15142210 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 38
Study 11408206 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 microg of rhG‐CSF/kg of body weight intravenously injected
Number of subjects: 25
Study 11408206 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ANC and CL(CR)
Number of subjects: 25
Study 11408206 — intervention group
Group type: EXPERIMENTAL
Intervention: CL(CR) in patients with ANC of <1,000/microl
Number of subjects: 25
Study 9741036 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (17 subjects) - kept 2-week food diaries under the belief that the researcher was verifying their report.
Number of subjects: 28
Study 9741036 — intervention group
Group type: COMPARATOR
Intervention: Control group (11 subjects) - asked to self-monitor for two more weeks without verification.
Number of subjects: 28
Study 7976985 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic aspirin therapy
Number of subjects: 0
Study 7976985 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy
Number of subjects: 0
Study 7976985 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine substitutes as adjunctive therapy in smoking cessation
Number of subjects: 0
Study 7976985 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blocker therapy following myocardial infarction
Number of subjects: 0
Study 7976985 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-inflammatory agents in the treatment of asthma
Number of subjects: 0
Study 7976985 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant drugs as therapy for mild depression
Number of subjects: 0
Study 7976985 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased fiber intake
Number of subjects: 0
Study 7976985 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular exercise
Number of subjects: 0
Study 2493342 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine
Number of subjects: 216
Study 2493342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 2493342 — intervention group
Group type: EXPERIMENTAL
Intervention: Stored samples
Number of subjects: 216
Study 31240711 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative colloid fluid bolus of 6 ml kg-1 lean body weight
Number of subjects: 80
Study 31240711 — intervention group
Group type: COMPARATOR
Intervention: No pre-operative fluid bolus
Number of subjects: 80
Study 28321566 — intervention group
Group type: EXPERIMENTAL
Intervention: C2 tDCS
Number of subjects: 42
Study 28321566 — intervention group
Group type: EXPERIMENTAL
Intervention: DLPFC tDCS
Number of subjects: 42
Study 28321566 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 42
Study 25374095 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg)
Number of subjects: 62
Study 25374095 — intervention group
Group type: COMPARATOR
Intervention: Midazolam (0.045 mg/kg)
Number of subjects: 62
Study 24011178 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation (one home visit followed by seven weekly telephone calls)
Number of subjects: 166
Study 24011178 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based pulmonary rehabilitation (twice weekly supervised exercise training and education for eight weeks)
Number of subjects: 166
Study 24011178 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based pulmonary rehabilitation
Number of subjects: 166
Study 24011178 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based pulmonary rehabilitation
Number of subjects: 166
Study 24011178 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based and hospital-based pulmonary rehabilitation
Number of subjects: 166
Study 21705173 — intervention group
Group type: EXPERIMENTAL
Intervention: OMS103HP
Number of subjects: 0
Study 21705173 — intervention group
Group type: COMPARATOR
Intervention: Control (lactated Ringer's)
Number of subjects: 0
Study 19148110 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous digoxin immune Fab (DIF)
Number of subjects: 26
Study 19148110 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 26
Study 16987678 — intervention group
Group type: EXPERIMENTAL
Intervention: neoadjuvant 5‐FU‐cisplatin based (13) or taxotere based (2 patients) chemoradiotherapy (45 Gy)
Number of subjects: 29
Study 16987678 — intervention group
Group type: COMPARATOR
Intervention: no preoperative treatment
Number of subjects: 29
Study 15334464 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual measurement of interbone distance (IBD) and percentage of radiographic magnification (%Mag)
Number of subjects: 15
Study 15334464 — intervention group
Group type: COMPARATOR
Intervention: Automated measurement of JSW
Number of subjects: 15
Study 15334464 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual measurement of JSW
Number of subjects: 15
Study 10637198 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodixanol (nonionic, iso-osmolar contrast medium)
Number of subjects: 1411
Study 10637198 — intervention group
Group type: COMPARATOR
Intervention: Ioxaglate (ionic, low-osmolar contrast medium)
Number of subjects: 1411
Study 9290688 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal heated chemotherapy (IPHC) with mitomycin (MMC) administered by perfusion at 40.5 degrees C
Number of subjects: 42
Study 9290688 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 42
Study 8305769 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin dosage adjustment using non-steady-state heparin concentrations (HCs)
Number of subjects: 34
Study 8305769 — intervention group
Group type: COMPARATOR
Intervention: Control group using only activated partial thromboplastin time (APTT)
Number of subjects: 34
Study 8305769 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study 8305769 — intervention group
Group type: EXPERIMENTAL
Intervention: HC group
Number of subjects: 34
Study 3525055 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal A (eggs, toasted wholemeal bread, orange juice, margarine, and milk)
Number of subjects: 8
Study 3525055 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal B (wheatflake biscuits, toasted wholemeal bread, milk, and margarine)
Number of subjects: 8
Study 3525055 — intervention group
Group type: EXPERIMENTAL
Intervention: Meal C (toasted muesli and skim milk)
Number of subjects: 8
Study 31439506 — intervention group
Group type: EXPERIMENTAL
Intervention: Superextended or extended lymph node dissection
Number of subjects: 0
Study 31439506 — intervention group
Group type: COMPARATOR
Intervention: Multimodal approaches including neoadjuvant or adjuvant chemotherapy
Number of subjects: 0
Study 29068266 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored internet-supported cognitive behaviour therapy (ICBT) programme
Number of subjects: 66
Study 29068266 — intervention group
Group type: COMPARATOR
Intervention: Weekly general support (Control)
Number of subjects: 66
Study 26631904 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine extract of onion (RO) (250 mL for 10 weeks)
Number of subjects: 23
Study 26631904 — intervention group
Group type: COMPARATOR
Intervention: Red wine (RW) (250 mL for 10 weeks)
Number of subjects: 23
Study 25085534 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol
Number of subjects: 490
Study 25085534 — intervention group
Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 490
Study 25085534 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 490
Study 25085534 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticholinergic drugs (most frequently in haloperidol group)
Number of subjects: 490
Study 25085534 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride, Olanzapine, Quetiapine, Ziprasidone
Number of subjects: 490
Study 22506942 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary HIV testing and brief counseling (VT/C)
Number of subjects: 1030
Study 20647102 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% EDTA for 1 minute (n = 30)
Number of subjects: 45
Study 20647102 — intervention group
Group type: EXPERIMENTAL
Intervention: 7% maleic acid for 1 minute (n = 30)
Number of subjects: 45
Study 20647102 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline for 1 minute (n = 30)
Number of subjects: 45
Study 17852312 — intervention group
Group type: EXPERIMENTAL
Intervention: Power-assisted functional electrical stimulation (FES) therapy, 30 sessions of approximately 60 min each, 6 days/week for 5 months
Number of subjects: 20
Study 17852312 — intervention group
Group type: EXPERIMENTAL
Intervention: Power-assisted functional electrical stimulation (FES) therapy
Number of subjects: 20
Study 14728936 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy (XRT-CT) with 5-FU 350 mg/m2/day and Leucovorin 20 mg/m2/day during the first and fifth weeks of XRT.
Number of subjects: 798
Study 14728936 — intervention group
Group type: COMPARATOR
Intervention: Preoperative radiation (XRT) with 45 Gy, 25 fractions over 5 weeks.
Number of subjects: 798
Study 14728936 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiotherapy (XRT-CT) with 5-FU- LV.
Number of subjects: 798
Study 14728936 — intervention group
Group type: COMPARATOR
Intervention: Preoperative radiation (XRT).
Number of subjects: 798
Study 11502644 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezosentan (20 mg/h)
Number of subjects: 14
Study 11502644 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezosentan (50 mg/h)
Number of subjects: 14
Study 11502644 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine (5 microg/kg/min)
Number of subjects: 14
Study 9267580 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgically assisted rapid maxillary expansion (SARME) with buccal corticotomies
Number of subjects: 42
Study 9267580 — intervention group
Group type: COMPARATOR
Intervention: Orthopedic expansion
Number of subjects: 42
Study 9267580 — intervention group
Group type: COMPARATOR
Intervention: Orthodontic treatment without expansion
Number of subjects: 42
Study 8492263 — intervention group
Group type: EXPERIMENTAL
Intervention: Dioralyte
Number of subjects: 9
Study 8492263 — intervention group
Group type: EXPERIMENTAL
Intervention: Lucozade
Number of subjects: 9
Study 8492263 — intervention group
Group type: COMPARATOR
Intervention: Potable water
Number of subjects: 9
Study 3509066 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-mg melatonin
Number of subjects: 10
Study 3509066 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-mg melatonin
Number of subjects: 10
Study 30971278 — intervention group
Group type: EXPERIMENTAL
Intervention: BCc1 nanomedicine (3000 mg for metastatic, 1500 mg for non-metastatic)
Number of subjects: 123
Study 30971278 — intervention group
Group type: EXPERIMENTAL
Intervention: BCc1 nanomedicine
Number of subjects: 123
Study 30971278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study 27543500 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g of calcium as citrate
Number of subjects: 40
Study 27543500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 27816567 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitopertin 10 mg (NightLyte)
Number of subjects: 1772
Study 27816567 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitopertin 20 mg (NightLyte)
Number of subjects: 1772
Study 27816567 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitopertin 10 mg (TwiLyte)
Number of subjects: 1772
Study 27816567 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitopertin 20 mg (TwiLyte)
Number of subjects: 1772
Study 27816567 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitopertin 5 mg (MoonLyte)
Number of subjects: 1772
Study 27816567 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitopertin 10 mg (MoonLyte)
Number of subjects: 1772
Study 27816567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1772
Study 25163483 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary nutritional support
Number of subjects: 0
Study 22493073 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCTZ) 25 to 50 mg
Number of subjects: 37
Study 22493073 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride (10-20 mg)
Number of subjects: 37
Study 22493073 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebivolol (5 to 10 mg)
Number of subjects: 37
Study 22493073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 19294950 — intervention group
Group type: EXPERIMENTAL
Intervention: REM sleep deprivation
Number of subjects: 12
Study 19294950 — intervention group
Group type: EXPERIMENTAL
Intervention: SWS deprivation
Number of subjects: 12
Study 19294950 — intervention group
Group type: COMPARATOR
Intervention: Undisturbed sleep
Number of subjects: 12
Study 17463213 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous midazolam 2 mg + oral aprepitant 125 mg
Number of subjects: 12
Study 17463213 — intervention group
Group type: COMPARATOR
Intervention: Intravenous midazolam 2 mg
Number of subjects: 12
Study 14997286 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip protectors (three pairs of 'shell' type)
Number of subjects: 4169
Study 14997286 — intervention group
Group type: COMPARATOR
Intervention: Control group (no hip protectors)
Number of subjects: 4169
Study 14997286 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular use of hip protectors
Number of subjects: 4169
Study 11104314 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment (Comb) group (medicated)
Number of subjects: 117
Study 11104314 — intervention group
Group type: COMPARATOR
Intervention: Behavioral treatment (Beh) group (unmedicated)
Number of subjects: 117
Study 9314913 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral micronized E2 (2 mg daily)
Number of subjects: 36
Study 9314913 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 8393365 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytosine arabinoside (ara-C) as a repair inhibitor of cyclophosphamide (Cy) resistance
Number of subjects: 67
Study 8393365 — intervention group
Group type: EXPERIMENTAL
Intervention: Etoposide plus cisplatin (EP)
Number of subjects: 67
Study 2873131 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (3.67 mg)
Number of subjects: 98
Study 2873131 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (167 mg)
Number of subjects: 98
Study 2873131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 2873131 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 98
Study 2873131 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 98
Study 30451806 — intervention group
Group type: EXPERIMENTAL
Intervention: BioTrue ONEday for Presbyopia
Number of subjects: 72
Study 30451806 — intervention group
Group type: EXPERIMENTAL
Intervention: Acuvue Moist Multifocal
Number of subjects: 72
Study 30451806 — intervention group
Group type: EXPERIMENTAL
Intervention: Dailies AquaComfort Plus Multifocal
Number of subjects: 72
Study 28827238 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced plate nutrition education with practical demonstration from community health workers 4-7 times throughout pregnancy
Number of subjects: 900
Study 28827238 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition education delivered by public and other healthcare providers
Number of subjects: 900
Study 28827238 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced plate nutrition education
Number of subjects: 900
Study 28827238 — intervention group
Group type: COMPARATOR
Intervention: Standard nutrition education
Number of subjects: 900
Study 25909463 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention in primary care teams
Number of subjects: 200
Study 25909463 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pharmacist intervention)
Number of subjects: 200
Study 24427663 — intervention group
Group type: EXPERIMENTAL
Intervention: Amphotericin B
Number of subjects: 26
Study 24427663 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole
Number of subjects: 26
Study 21219391 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcelain-fused-to-metal (PFM)
Number of subjects: 20
Study 21219391 — intervention group
Group type: COMPARATOR
Intervention: All-ceramic
Number of subjects: 20
Study 21219391 — intervention group
Group type: COMPARATOR
Intervention: Both PFM and all-ceramic
Number of subjects: 20
Study 18502262 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenofibrate (FENO) 160 mg/day
Number of subjects: 0
Study 18502262 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe (EZE) 10 mg/day
Number of subjects: 0
Study 18502262 — intervention group
Group type: EXPERIMENTAL
Intervention: Coadministration of FENO + EZE
Number of subjects: 0
Study 18502262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 17333838 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy using delta‐aminolevulinic acid in a water‐in‐oil emulsion applied to lesions, repeated once a week for a month
Number of subjects: 5
Study 12804082 — intervention group
Group type: EXPERIMENTAL
Intervention: Throat Coat (5-8 oz, 4-6 times daily)
Number of subjects: 60
Study 12804082 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5-8 oz, 4-6 times daily)
Number of subjects: 60
Study 11191784 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifting a 15-kg weight from elbow to shoulder level
Number of subjects: 16
Study 11191784 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymmetric lifting
Number of subjects: 16
Study 11191784 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 degrees right lateral plane lifting
Number of subjects: 16
Study 11191784 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifting a 15-kg weight
Number of subjects: 16
Study 9175683 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 90
Study 9175683 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol
Number of subjects: 90
Study 1437248 — intervention group
Group type: EXPERIMENTAL
Intervention: Clyburn dynamic external fixator
Number of subjects: 70
Study 1437248 — intervention group
Group type: COMPARATOR
Intervention: Forearm plaster
Number of subjects: 70
Study 31839677 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel plus MEK inhibitor selumetinib
Number of subjects: 0
Study 31839677 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30855741 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible duty-hour policies (maintaining an 80-hour workweek without limits on shift length or mandatory time off between shifts)
Number of subjects: 398
Study 30855741 — intervention group
Group type: COMPARATOR
Intervention: Standard duty-hour policies (2011 regulations)
Number of subjects: 398
Study 30855741 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible duty-hour policies
Number of subjects: 398
Study 30855741 — intervention group
Group type: COMPARATOR
Intervention: Standard duty-hour policies
Number of subjects: 398
Study 27694160 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based peer support programme (24-month intervention with regular group meetings facilitated by trained peer supporters).
Number of subjects: 261
Study 27694160 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard disease management programme without peer support).
Number of subjects: 261